Q3 2018

Filed Nov 6, 2018 · 10-Q · 37 days after period end · 0000877860-18-000077

Q3 2018 · 10-Q

Revenue

$74.92M

+5.0% vs Q3 2017

Net Income

$40.98M

+4.8% vs Q3 2017

EPS Diluted

$0.97

+3.2% vs Q3 2017

Operating Income$40,979,000+4.8%

Operating Cash Flow

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	$74.92M	$71.35M	$63.25M	$58.28M
Net Income	$40.98M	$39.09M	$33.03M	$33.60M
EPS Diluted	$0.97	$0.94	$0.83	$0.89

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR